
About T1D Fund
T1D Fund is a Financial Services company based in Boston (United States). Companies developing T1D products are funded through venture philanthropy. It operates on a B2B model. Its focus areas include Investment Industry, Venture Capital Funds, Independent Funds and Conventional VCs.
Company details
Investments are directed by the T1D Fund toward companies advancing Type 1 Diabetes (T1D) products within the biotechnology sector. Operations are centered in Boston, United States, with a focus on venture philanthropy to support innovative treatments. The portfolio encompasses firms like Bigfoot Biomedical, Diasome Pharmaceuticals, and eGenesis Bio, where financial and strategic backing is provided to accelerate T1D solutions.
- Headquarters Boston, United States
- SectorsFinancial Services
- Website t1dfund.org
People of T1D Fund
2 people are tracked at T1D Fund (2 in team).
| Name | Role | Group |
|---|---|---|
Daniel Flicker | Senior Associate | Team |
Morgan Janes | Associate | Team |
Complete people profiles for T1D Fund
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Top companies in Venture Capital Funds
3 companies that operate in the same segment as T1D Fund (Venture Capital Funds) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Venture capital firm investing in early-stage tech startups | 1972 | Menlo Park, California, United States | ||||
Venture capital investments and support for entrepreneurs in technology and innovation sectors. | 1911 | Redwood City, California, United States | USD 691.23 K | |||
Accel is recognized as a leading venture capital firm. | 1983 | Palo Alto, California, United States |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about T1d Fund
Complete news archive for T1D Fund
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about T1D Fund
T1D Fund is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
Investments are directed by the T1D Fund toward companies advancing Type 1 Diabetes (T1D) products within the biotechnology sector. Operations are centered in Boston, United States, with a focus on venture philanthropy to support innovative treatments. The portfolio encompasses firms like Bigfoot Biomedical, Diasome Pharmaceuticals, and eGenesis Bio, where financial and strategic backing is provided to accelerate T1D solutions.
